Fennec Pharmaceuticals (FENC) Share-based Compensation Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 124.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 124.38% |
| Sep 30, 2025 | 21.86% |
| Jun 30, 2025 | 61.51% |
| Mar 31, 2025 | -33.00% |
| Dec 31, 2024 | 31.16% |
| Sep 30, 2024 | 110.52% |
| Jun 30, 2024 | -63.63% |
| Mar 31, 2024 | 9.37% |
| Dec 31, 2023 | 2,756.67% |
| Sep 30, 2023 | 2,444.12% |
| Jun 30, 2023 | 7,165.71% |
| Mar 31, 2023 | 3,102.94% |
| Dec 31, 2022 | -99.20% |
| Sep 30, 2022 | -96.29% |
| Jun 30, 2022 | -97.36% |
| Mar 31, 2022 | -94.21% |
| Dec 31, 2021 | 17,709.52% |
| Sep 30, 2021 | -25.93% |
| Jun 30, 2021 | 6,214.29% |
| Mar 31, 2021 | 50.13% |
| Dec 31, 2020 | 110.77% |
| Sep 30, 2020 | 5,795.24% |
| Jun 30, 2020 | -93.66% |
| Mar 31, 2020 | 76.92% |
| Dec 31, 2019 | -112.33% |
| Sep 30, 2019 | -54.35% |
| Jun 30, 2019 | 298.80% |
| Mar 31, 2019 | 27.01% |
| Dec 31, 2018 | 63.94% |
| Sep 30, 2018 | -94.93% |
| Jun 30, 2018 | -70.98% |
| Mar 31, 2018 | 210.71% |
| Dec 31, 2017 | 1,607.81% |
| Sep 30, 2017 | 3,139.29% |
| Jun 30, 2017 | 1,582.35% |
| Dec 31, 2016 | -172.73% |
| Dec 31, 2015 | -51.91% |
| Mar 31, 2015 | -93.02% |
| Dec 31, 2014 | 622.86% |
| Sep 30, 2014 | 197.56% |
| Dec 31, 2013 | -125.74% |
| Jun 30, 2013 | 70.59% |
| Jun 30, 2012 | -65.31% |
| Sep 30, 2011 | -66.58% |
| Jun 30, 2011 | -97.61% |